QQQ

DIA

SPY

TLT

GLD

BTC/USD

QQQ

DIA

SPY

TLT

GLD

BTC/USD

Range

- - -

Vol / Avg.

-/10.7M

Div / Yield

-

52 Wk

1.94 - 10.89

Mkt Cap

1.4B

Payout Ratio

-

Open

-

P/E

10.62

EPS

-0.33

Shares

233.7M

Outstanding

233.7M

Total Float

168.4M

Analyst Ratings

Endo's Qwo Data Presented At American Society For Dermatologic Surgery's Annual Meeting

Benzinga - Nov 22, 2021, 10:57AM

Endo Int'l. Reports Begun Shipping Generic MIACALCIN Injection

Benzinga - Nov 18, 2021, 7:40AM

Endo Announces Fill-Finish Manufacturing Agreement With US Government To 'Support Production of Critical Medicines'

Benzinga - Nov 17, 2021, 7:41AM

Endo Announces Agreement With Premier To Supply VASOSTRICT Vials, Essential For COVID-19 Care

Benzinga - Nov 8, 2021, 7:31AM

Endo International shares are trading higher after the company reported better-than-expected Q3 EPS and sales results. The company also raised its FY21 EPS and sales guidance above analyst estimates.

Benzinga - Nov 5, 2021, 2:17PM

Endo Raises FY21 Total Sales From $2.73B-$2.79B To $2.9B-$2.94B vs $2.79B Estimate, Adj. EPS $2.15-$2.30 To $2.80-$2.85 vs $2.33 Est.

Benzinga - Nov 4, 2021, 6:02PM

Endo International Q3 Adj. EPS $0.80 Beats $0.48 Estimate, Sales $772.03M Beat $669.71M Estimate; Raises Guidance

Benzinga - Nov 4, 2021, 6:01PM

Endo International shares are trading higher after the company reported the California state court issued a tentative ruling in Endo's favor following the opioid trial.

Benzinga - Nov 2, 2021, 7:50AM

California Judge Rules For Drugmakers In Major Opioid Litigation

Benzinga - Nov 2, 2021, 7:20AM

Endo Int'l. Reports California State Court Tentatively Ruled Defendants, Including Co.'s Endo Health Solutions, Endo Pharma Units, Not Liable

Benzinga - Nov 2, 2021, 7:08AM

Endo Int'l. Highlights Post-Hoc Data From 2 Phase 3 Studies Of XIAFLEX For Men With Peyronie's Disease Will Be Presented At Sexual Medicine Society Of North America Meeting Oct. 22

Benzinga - Oct 22, 2021, 7:04AM

Endo Presents New Investigational Collagenase Clostridium Histolyticum (Cch) Survey Data At American Society For Surgery Of The Hand (Assh) Annual Meeting

Benzinga - Sep 30, 2021, 11:09AM

Endo Reaches Agreement in Principle To Settle Louisiana Governmental Opioid Cases And Claims; Will Pay Total Of $7.5M

Benzinga - Sep 28, 2021, 2:00PM

Endo international shares are trading higher after the company announced the launch of a generic version of Chantix tablets in the US.

Benzinga - Sep 22, 2021, 12:48PM

Endo Launches Generic Version Of Pfizer's Smoking Cessation Pill

Benzinga - Sep 22, 2021, 12:39PM

Endo Highlights Launch Of Generic Version Of Chantix Tablets In US

Benzinga - Sep 22, 2021, 10:06AM

Why Shares Of Endo International Surged On Friday

Benzinga - Sep 10, 2021, 3:51PM

load more

Sector: Health Care.Industry: Pharmaceuticals

Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, and others. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. Some of its products include XIAFLEX, SUPPRELIN, PERCOCET, TESTOPEL, VASOSTRICT, ADRENALIN, and APLISOL. The majority of its revenue comes from the United States.

Earnings

Q4 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2022-02-24
REV		(EXPECTED)2022-02-24

Q3 2021		Est.		Actual		Surprise
EPS		0.480		0.800		0.3200
REV		669.710M		772.028M		102.318M

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Endo International Questions & Anwsers

Q

How do I buy Endo International (ENDP) stock?

A

You can purchase shares of Endo International (NASDAQ: ENDP) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Endo International's (ENDP) competitors?

A

Other companies in Endo International’s space includes: Sundial Growers (NASDAQ:SNDL), Reata Pharmaceuticals (NASDAQ:RETA), Supernus Pharmaceuticals (NASDAQ:SUPN), DICE Therapeutics (NASDAQ:DICE) and Phibro Animal Health (NASDAQ:PAHC).

Q

What is the target price for Endo International (ENDP) stock?

A

The latest price target for Endo International (NASDAQ: ENDP) was reported by RBC Capital on August 9, 2021. The analyst firm set a price target for 5.00 expecting ENDP to fall to within 12 months (a possible -14.38% downside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Endo International (ENDP)?

A

The stock price for Endo International (NASDAQ: ENDP) is $5.84 last updated Mon Nov 29 2021 21:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does Endo International (ENDP) pay a dividend?

A

There are no upcoming dividends for Endo International.

Q

When is Endo International (NASDAQ:ENDP) reporting earnings?

A

Endo International’s $Q4 earnings are confirmed for after-market on February 24, 2022.

Q

Is Endo International (ENDP) going to split?

A

There is no upcoming split for Endo International.

Q

What sector and industry does Endo International (ENDP) operate in?

A

Endo International is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.